Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • InderesTV
  • Portfölj
  • Forum
  • Nora AI
  • Q&A
  • Om oss
    • Bolag under bevakning
    • Teamet
Regulatoriskt pressmeddelande

ContextVision - Mandatory notification of trade - primary insider

ContextVision
STOCKHOLM - November 02 2022 - Gerald Pötzsch, CEO of ContextVision, has during
the period of August 31[st] until November 1[st], 2022 purchased 10.000 shares
in ContextVision AB at an average price of NOK 8,71 per share. After the
transaction, Mr Pötzsch holds a total of 15.000 shares in ContextVision AB.

With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"),
kindly note the following primary insider share transaction:

Name of listed entity: ContextVision AB
ISIN number: SE0014731154
Stock ticker: CONTX
Name of primary insider: Gerald Pötzsch
Relation to listed entity: CEO
Trade: 10.000 shares
Date: 01.11.2022
Average purchase price: NOK 8,71 per share
Primary insider's total shareholdings post-purchase: 15.000 shares
Primary insider's percentage shareholding post-purchase: 0,02%

###

For further information, please contact ContextVision's CEO, Gerald Pötzsch, at
+46 8 750 35 50 or gerald.potzsch@contextvision.com or
visit www.contextvision.com (https://www.globenewswire.com/Tracker?data=3MaQGqfS
t
sB_Z2n6YL96mk
-0dfygLw6oN4eKvMWXKupICwsDDzA5ube1toUXebPYzar4qnu3TeaXF33IVlLZ60EyMCEFEOWZap0EhV
S
qE-zUKei2pFNr5cBFltRYMNo6kn7oL7CJxcgVx-hYON67FOGIkP2rl4
-54NJMeD5MzrIVSQFWmgmZB085ANCWw_
-3WhU_QFycYwSw79n9hRO8bD7Hmgptb56Phn4abKPm1hKO_3dkThorqVpb9FHkE5KXb2U2zArc9gueaS
X
iPxhqyw==).

###

About ContextVision
ContextVision is a medical technology software company specialized in image
analysis and artificial intelligence. As the global market leader within image
enhancement, we are a trusted partner to leading manufacturers of ultrasound, X
-ray and MRI equipment around the world.

Our expertise is to develop powerful software products, based on proprietary
technology and artificial intelligence for image-based applications. Our cutting
-edge technology helps clinicians accurately interpret medical images, a crucial
foundation for better diagnosis and treatment.

The company, established in 1983, is based in Sweden with local representation
in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock
Exchange under the ticker CONTX.
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.